Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

Yang-Liu Shao, Jingjing Yang, Xiaobo Li, Di Guan, Xiawei Zhang, Wu Tong, Zeliang Song, Dao Wang, Zhijie Wei, Jingbo Wang, Xiangjun Liu, Yuelin He, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 3573.

https://doi.org/10.1182/blood-2024-203190

Published: 2024

Journal Articles

CMV-Specific TCR-T Cells for the Treatment of CMV Reactivation after Allogeneic Hematopoietic Stem-Cell Transplantation

Jingwen Tang, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 3462.

https://doi.org/10.1182/blood-2024-204804

Published: 2024

Journal Articles

Lymphocyte Dynamics during the Treatment of SR-aGVHD with Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood - a Phase III, Multi-Center, Prospective, Single-Arm Pivotal Study

Sheng Chen, Dongxue Ge, Kun Qian, Jingwen Tang, Yujun Wei, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 2135.

https://doi.org/10.1182/blood-2024-204735

Published: 2024

Journal Articles

Phase Ⅱ Study of Chidamide in Combination with Dcag and Venetoclax for Refractory/Relapsed Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Qingyang Liu, Yanan Wen, Xiawei Zhang, Wenjing Gao, Daihong Liu, Liping Dou

Blood (2024) 144 (Supplement 1): 6070.

https://doi.org/10.1182/blood-2024-204739

Published: 2024

Journal Articles

A Phase I Study of Chidamide in Combination with Dcag and Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Xiawei Zhang, Jingjing Yang, Sai Huang, Qingyang Liu, Liping Dou, Chunji Gao, Daihong Liu

Blood (2024) 144 (Supplement 1): 1519.

https://doi.org/10.1182/blood-2024-204782

Published: 2024

Journal Articles

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Blood (2023) 142 (Supplement 1): 1207.

https://doi.org/10.1182/blood-2023-181622

Published: 2023

Journal Articles

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

Liping Dou, Yanli Zhao, Lei Deng, Fang Zhou, Nan Wang, Xiangshu Jin, Fei Li, Liangding Hu, Daihong Liu

Blood (2022) 140 (Supplement 1): 1381–1382.

https://doi.org/10.1182/blood-2022-158162

Published: 2022

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Blood (2022) 140 (Supplement 1): 2306–2307.

https://doi.org/10.1182/blood-2022-164637

Published: 2022

Journal Articles

Individualized Dosing of Anti-Thymocyte Globulin Led to Reduced CMV/EBV Reactivation and Superior Overall Survival in Adult Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Phase II Study

Haitao Wang, Liping Dou, Lili Wang, Bo Peng, Nan Wang, Yingxin Zhao, Jishan Du, Daihong Liu

Blood (2022) 140 (Supplement 1): 4753–4754.

https://doi.org/10.1182/blood-2022-158994

Published: 2022

Journal Articles

Prophylactic Modified Donor Lymphocyte Infusion after Allogeneic Peripheral Blood Stem Cell Transplantation for Very High-Risk Hematological Malignancies: Low Incidence of Relapse without Increasing the Risk of Graft-Versus-Host Disease

Xiaoning Gao, Shuhong Wang, Wenrong Huang, Honghua Li, Yu Jing, Liping Dou, Fei Li, Lili Wang, MD PhD, Xiaolin Lu, Jing Chen, MD, Lijun Wang, Xiangshu Jin, Li Yu, Daihong Liu

Blood (2017) 130 (Supplement 1): 2002.

https://doi.org/10.1182/blood.V130.Suppl_1.2002.2002

Published: 2017

Journal Articles

The Efficacy of CT-Diagnostic-Driven Antifungal Strategy with Voriconazole for Invasive Aspergillosis in Patients with Hematological Diseases: A Multicenter, Prospective Study

Yu Ji, Yuqian Sun, Chenhua Yan, Xiaojun Huang, Daihong Liu, Qifa Liu

Blood (2016) 128 (22): 2370.

https://doi.org/10.1182/blood.V128.22.2370.2370

Published: 2016

Journal Articles

Non-Traditional CD4+ CD25–CD69+ Regulatory T Cells Is Correlated To Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Xiaosu Zhao, Xuhua Wang, Yingjun Chang, Xiangyu Zhao, Xiaohui Zhang, Daihong Liu, Lanping Xu, Kaiyan Liu, Xiaojun Huang, MD

Blood (2013) 122 (21): 3259.

https://doi.org/10.1182/blood.V122.21.3259.3259

Published: 2013

Journal Articles

Lacking Of Missing Killer-Immunoglobulin-Like Receptor Ligand In Recipients Can Predict Better Prognosis After HLA-Mismatched/Haploidentical Transplantation Without T Cells Depletion In Vitro In Chronic Myeloid Leukemia Patients

Xiangyu Zhao, Yingjun Chang, Ling-Ling Xu, Mingrui Huo, Xiaosu Zhao, Lanping Xu, Daihong Liu, Kaiyan Liu, Dan Li, Xiaojun Huang

Blood (2013) 122 (21): 2165.

https://doi.org/10.1182/blood.V122.21.2165.2165

Published: 2013

Journal Articles

Rituximab-Based Treatments Followed By Adoptive Cellular Therapies For EBV-Associated Post-Transplant Lymphoproliferative Disease In Recipients Of Allogeneic Hematopoietic Stem Cell Transplantation

Xinmiao Jiang, Lanping Xu, Yu Zhang, Fen Huang, MD, Daihong Liu, Jing Sun, MD, Chaoyang Song, Xinquan Liang, Zhiping Fang, Hongsheng Zhou, Min Dai, Can Liu, Ph.D, Qianli Jiang, Na Xu, Li Xuan, Meiqing Wu, Xiaojun Huang, Qifa Liu, M.D.

Blood (2013) 122 (21): 4637.

https://doi.org/10.1182/blood.V122.21.4637.4637

Published: 2013

Journal Articles

KIT Mutation Versus MRD, Which Is More Important To Predict Relapse Of Acute Myeloid Leukemia With t (8; 21)?

Hong-Hu Zhu, MD, Daihong Liu, Hao Jiang, Ya-Zhen Qin, MS, Lan-Ping Xu, MD, Qian Jiang, Xiao-Hui Zhang, M.D., Ph.D., Huan Chen, Jin Lu, MD, Yu Wang, Li-Ru Wang, MD, Jun-Yue Chai, MM, Kai-Yan Liu, MD, Bin Jiang, MD, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 1309.

https://doi.org/10.1182/blood.V122.21.1309.1309

Published: 2013

Journal Articles

Graft-Versus-Host Disease Following Myeloablative Busulfan Plus Fludarabine and Busulfan Plus Cyclophosphamide For Allogeneic Hematopoietic Stem Cell Transplantation In Acute Myeloid Leukemia In First Complete Remission

Qifa Liu, MD, Hui Liu, Daihong Liu, Yongrong Lai, MD, Jing Sun, MD, Chaoyang Song, Yu Zhang, Yang Xiao, MD, Fen Huang, MD, Hongsheng Zhou, Zhiping Fan, Xutao Guo, M.D., Danian Nie, MD, Guopan Yu, MD&M Sci, Xiaojun Huang

Blood (2013) 122 (21): 3290.

https://doi.org/10.1182/blood.V122.21.3290.3290

Published: 2013

Journal Articles

Prolonged Thrombocytopenia Is Associated With Increases Of CD8+ CX3CR1+ Cells In The Bone Marrow After Allogeneic Hematopoietic Stem Cell Transplantation

Xiaohui Zhang, Guoxiang Wang, Honghu Zhu, Yanrong Liu, MD, PhD, Daihong Liu, Lanping Xu, Wei Han, Huan Chen, Yuhong Chen, Feng-Rong Wang, Kaiyan Liu, Xiaojun Huang, M.D Ph.D

Blood (2013) 122 (21): 5494.

https://doi.org/10.1182/blood.V122.21.5494.5494

Published: 2013

Journal Articles

Intracranial Hemorrhage and Mortality In 1461 Patients After Allogeneic Hematopoietic Stem Cell Transplantation For 6-Year Follow-Up: Study Of 44 Cases

Xiaohui Zhang, Wei Han, Yuhong Chen, Huan Chen, Daihong Liu, Lanping Xu, Kaiyan Liu, Xiaojun Huang, M.D Ph.D

Blood (2013) 122 (21): 3322.

https://doi.org/10.1182/blood.V122.21.3322.3322

Published: 2013

Journal Articles

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

Hao Jiang, Daihong Liu, Lanping Xu, Kaiyan Liu, Shanshan Chen, MD, Bin Jiang, MD, Qian Jiang, Huan Chen, Yuhong Chen, Wei Han, MD, Xiaohui Zhang, Yazhen Qin, Yueyun Lai, Yanrong Liu, MD, PhD, Xiaojun Huang

Blood (2013) 122 (21): 4035.

https://doi.org/10.1182/blood.V122.21.4035.4035

Published: 2013

Journal Articles

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Lanping Xu, Daihong Liu, Kaiyan Liu, MD, Chunli Zhang, Fengrong Wang, Jingzhi Wang, Yu Wang, MD, Huan Chen, Yuanyuan Zhang, Chenhua Yan, Wei Han, MD, Yuhong Chen, MD, PhD, Ting Zhao, Xiao-Hui Zhang, Xiaojun Huang

Blood (2012) 120 (21): 4512.

https://doi.org/10.1182/blood.V120.21.4512.4512

Published: 2012

NARROW

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

CMV-Specific TCR-T Cells for the Treatment of CMV Reactivation after Allogeneic Hematopoietic Stem-Cell Transplantation

Lymphocyte Dynamics during the Treatment of SR-aGVHD with Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood - a Phase III, Multi-Center, Prospective, Single-Arm Pivotal Study

Phase Ⅱ Study of Chidamide in Combination with Dcag and Venetoclax for Refractory/Relapsed Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

A Phase I Study of Chidamide in Combination with Dcag and Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Individualized Dosing of Anti-Thymocyte Globulin Led to Reduced CMV/EBV Reactivation and Superior Overall Survival in Adult Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Phase II Study

Prophylactic Modified Donor Lymphocyte Infusion after Allogeneic Peripheral Blood Stem Cell Transplantation for Very High-Risk Hematological Malignancies: Low Incidence of Relapse without Increasing the Risk of Graft-Versus-Host Disease

The Efficacy of CT-Diagnostic-Driven Antifungal Strategy with Voriconazole for Invasive Aspergillosis in Patients with Hematological Diseases: A Multicenter, Prospective Study

Non-Traditional CD4+ CD25–CD69+ Regulatory T Cells Is Correlated To Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Lacking Of Missing Killer-Immunoglobulin-Like Receptor Ligand In Recipients Can Predict Better Prognosis After HLA-Mismatched/Haploidentical Transplantation Without T Cells Depletion In Vitro In Chronic Myeloid Leukemia Patients

Rituximab-Based Treatments Followed By Adoptive Cellular Therapies For EBV-Associated Post-Transplant Lymphoproliferative Disease In Recipients Of Allogeneic Hematopoietic Stem Cell Transplantation

KIT Mutation Versus MRD, Which Is More Important To Predict Relapse Of Acute Myeloid Leukemia With t (8; 21)?

Graft-Versus-Host Disease Following Myeloablative Busulfan Plus Fludarabine and Busulfan Plus Cyclophosphamide For Allogeneic Hematopoietic Stem Cell Transplantation In Acute Myeloid Leukemia In First Complete Remission

Prolonged Thrombocytopenia Is Associated With Increases Of CD8+ CX3CR1+ Cells In The Bone Marrow After Allogeneic Hematopoietic Stem Cell Transplantation

Intracranial Hemorrhage and Mortality In 1461 Patients After Allogeneic Hematopoietic Stem Cell Transplantation For 6-Year Follow-Up: Study Of 44 Cases

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only